e-ASIA Joint Research Program (the e-ASIA JRP): Research Cooperation in the field of ‘Health Research’

The e-ASIA Joint Research Program (hereinafter referred to as the “e-ASIA JRP”) aims to develop a vibrant and collaborative research community in Science and Technology, to promote innovation in the East Asian region, and to contribute to the region’s economic development. As part of the program, the Member Organizations of the eASIA JRP listed below have agreed to implement a joint call for proposals of multilateral cooperative research activities.

Participating Member Organizations (listed in alphabetical order)
1) Australia: National Health and Medical Research Council (NHMRC)
2) Indonesia: National Research and Innovation Agency (BRIN)
3) Japan: Japan Agency for Medical Research and Development (AMED)
4) Lao PDR: Ministry of Health (MOH)
5) Philippines: Department of Science and Technology (DOST-PCHRD)
6) Singapore: Agency for Science, Technology and Research (A*STAR)
7) USA: National Institute of Allergy and Infectious Diseases (NIAID)


Application submission and
correspondence may send by email to dana-risnov@brin.go.id. The deadline for submitting your proposal is March 8th, 2024. You do not need to submit a proposal if you are merely a team member and not the Lead PI. Detail application process, links to guidance/policy materials can be seen here https://pendanaan-risnov.brin.go.id

Possible research topics in infectious diseases and immunology include the following,
but are not limited to:
• Intersections between chronic and infectious disease, including co- and multi-morbidities
o common risk factors that aggravate the condition (e.g. tobacco, obesity)
o immune response, inflammation, metabolism, and microbiome
• Novel vaccine immunogens for combatting emerging and re-emerging infectious diseases
• Utilization of microfluidics for discovery of antibody-based therapeutics against antimicrobial resistance
• Pandemic preparedness and response (e.g., surveillance, interventions, public awareness and prevention, vaccine development, climate change)
• Multi-OMICS approach towards discovery and innovation – Host immune responses to infectious diseases
• Novel antibody therapeutics and vaccine immunogens for combatting antimicrobial-resistant pathogens
• Effective public health infection control and prevention methods

More info: e-ASIA JRP (the-easia.org)

guidline: guideline_13th_health

Application form: applicationform_13th_health